THE STETHO https://thestetho.com/index.php/ts <p><strong>THE STETHO</strong> is a Quarterly Journal of Innovations &amp; Advances in Basic and Medical Sciences. The Journal aims to add significant medical literature for the improvement in the field of medicine. The Journal provides Swift, Affordable, Prompt, Open Access and Fast Track Blin Peer-Reviewed &amp; Editorial Reviewed Publications. The Journal's DOI operated by <strong>Zenodo</strong>. All articles Indexed are in <strong>OpenAIRE</strong>.</p> <p class="p1"><strong>THE STETHO is Indexed in <a href="http://journal-index.org/index.php/asi/article/view/7162" target="_blank" rel="noopener">ADVANCED SCIENCES INDEX</a> <span class="s1">™ (ASI) </span>CENTRAL EUROPEAN SCIENCE EVALUATION <span class="s2">| </span>Neredataltics™ UG, Germany.</strong></p> <p class="p1">The International Centre for the registration of serial publications (CIEPS – <a href="https://portal.issn.org/resource/ISSN/2709-5991">ISSN</a> International Centre), located in Paris 75003 (France), 45 rue de Turbigo, certifies that <strong>ISSN 2709-5991</strong> is provisionally assigned to THE STETHO.</p> <p class="p1"><strong>THE STETHO is line with the standards of ICMJE (International Committee of Medical Journal Editors) and is a Member of ICMJE <a href="http://www.icmje.org/journals-following-the-icmje-recommendations/" target="_blank" rel="noopener">www.icmje.org</a> | <sub>Hosted by</sub> <a href="http://www.annals.org/" target="_blank" rel="noopener">Annals of Internal Medicine</a> / <a href="http://www.acponline.org/" target="_blank" rel="noopener">American College of Physicians</a>, USA.</strong></p> <p class="p1">The Journal is also Indexed in <a href="https://europub.co.uk/journals/27491" target="_blank" rel="noopener">EuroPub</a> Directory of Academic and Scientific Journals, <a href="http://sjifactor.com/passport.php?id=21401" target="_blank" rel="noopener">SJIF</a>|SJIFactor.com, <strong><a href="http://esjindex.org/search.php?id=4829" target="_blank" rel="noopener">ESJI</a> | © ESI Eurasian Scientific Journal indexing and impact Factor Calculation service based on Eurasian Citation Reports and Eurasian Scientific Index, Cosmos <a href="http://www.cosmosimpactfactor.com/page/journals_details/6375.html" target="_blank" rel="noopener">Impact Factor</a>, <span class="css-901oao css-16my406 r-poiln3 r-bcqeeo r-qvutc0">Index Medicus. IMEMR Journals Directory (<a href="https://vlibrary.emro.who.int/journals/the-stetho/" target="_blank" rel="noopener">IMJD</a>)</span> and <a href="https://portal.issn.org/resource/ISSN/2709-5991" target="_blank" rel="noopener">THE KEEPERS</a> | Keepers Registry ISSN © 2021 - keepers.issn.org</strong></p> <p class="p1">The Journal routinely screen article submissions for plagiarism and uses the academic software Turnitin for this purpose and takes editorial decision to reject the submission if the plagiarism (Similarity Index) is more than 18% (Overall) or more than 5% from a single source.</p> <p class="p1">The Journal has specially designed Fast Track Peer Review at no additional cost for those seeking publications for <strong>CIP (Central Induction Policy)</strong>.</p> <p class="p1"><strong>Copyright (c) 2020 THE STETHO <a href="https://creativecommons.org/licenses/by-sa/4.0/" target="_blank" rel="license noopener"><img src="https://thestetho.com/public/site/images/shamir/80x15.png" alt="Creative Commons License" width="80" height="15" /></a>. This work is licensed under a <a href="https://creativecommons.org/licenses/by-sa/4.0/" rel="license">Creative Commons Attribution-ShareAlike 4.0 International License</a>.</strong></p> en-US chiefeditor@thestetho.com (Dr Syed Shahmeer Raza) shahrukhhijaz@gmail.com (Dr Asfandiar Shah Rukh Hijaz) Thu, 10 Oct 2024 20:40:43 +0000 OJS 3.2.1.1 http://blogs.law.harvard.edu/tech/rss 60 Assessment of Breast Tumor Response to Neoadjuvant Chemotherapy Using Tomographic Diffuse Optical Spectroscopy: Case Studies on Changes in Tumor Regions https://thestetho.com/index.php/ts/article/view/81 <p>This study evaluates two methods for region-of-interest (ROI) analysis to summarize tomographic diffuse optical spectroscopic (DOS) data, aiming to differentiate between complete and partial responses in patients undergoing neoadjuvant therapy for locally advanced breast cancer. Both fixed-size and variable-size ROI (full-width-at-half-maximum) methods are considered. Adjacent and opposite breast optical scattering amplitude, power, water percentage, total levels of haemoglobin (HbT), and blood oxygen saturation are some important parameters examined. Institutional review board approval and HIPAA compliance were secured, and participants provided informed consent and received compensation. In this analysis, seven of 16 patients with complete data sets were included. Postsurgical histopathologic examination categorized patients into complete response (pCR) and partial response (pIR) groups. Significant differences (P ≤ .05) in the average normalized change in HbT were observed between pCR and pIR groups. The pCR group exhibited a mean HbT change of −64.2% ± 50.8 for fixed-size ROIs and −96.7% ± 91.8 for variable-size ROIs, while the pIR group showed mean changes of 16.9% ± 38.2 and 14.1% ± 26.7, respectively. These findings suggest that tomographic DOS can potentially provide valuable predictive information on treatment responses, which could enhance personalized patient care.&nbsp;</p> Usman Muhammad Qazi, Feroz Ali Khan, Samya Naqshbandi, Ali Muhammad Qazi, Muhammad Fawad Khan, Pankaj Pankaj Copyright (c) 2024 THE STETHO https://creativecommons.org/licenses/by/4.0 https://thestetho.com/index.php/ts/article/view/81 Thu, 10 Oct 2024 00:00:00 +0000 Handbook of Common Urology Cases https://thestetho.com/index.php/ts/article/view/83 Amer Kamal Hussain, Muhammad Raheel, Ayman Mohammed Nour Copyright (c) 2024 THE STETHO https://creativecommons.org/licenses/by/4.0 https://thestetho.com/index.php/ts/article/view/83 Sat, 12 Oct 2024 00:00:00 +0000 Excision of a Left Atrial Myxoma Turns Out to be a Rare Presentation of Diffuse Large B-cell Lymphoma on Histopathology https://thestetho.com/index.php/ts/article/view/79 <p>Cardiac myxomas are benign primary tumors of the heart, accounting for approximately 50% of all primary heart tumors. A 50 years old female presented to the outpatient department with complaints of shortness of breath on exertion, palpitations, and easy fatigability ongoing for a period of six to eight months. Echocardiography findings revealed a large mass about 4.9 cm<sup>2</sup> in the left atrium, suggestive of atrial myxoma with mild mitral regurgitation. She was planned for open heart surgical excision of her LA-Myxoma. The patient tolerated the procedure well and had an uneventful post-operative course. Histological evaluation of the specimen led to the diagnosis of a Diffuse Large B-Cell Lymphoma. Patient recovered well and was referred to oncological facility, where she was started on chemotherapy sessions. At 06 months follow up patient was seen in good cardiac health and no residual cardiac dysfunction, mass or defect. No matter how classical clinical and imaging presentation in favor of benign myxoma may be, the tissue must be sent for appropriate histological examination and tissue diagnosis when excised through indicated cardiac surgery.</p> Muhammad Aasim, Raheel Khan, Attaul Muhsin, Raheela Aziz Copyright (c) 2024 THE STETHO https://creativecommons.org/licenses/by/4.0 https://thestetho.com/index.php/ts/article/view/79 Thu, 10 Oct 2024 00:00:00 +0000